Research & Development



  天黑暗下來,一片破舊的平房像城市的疥癬,骯髒丑陋,只有一小半亮著燈光。我穿過臭烘烘的小路,來到寧家門前。往事不由得涌上心頭,我與寧恆上中學時就認識,常來這里玩,他的父親是個豪爽的男人,母親悶悶地不愛說話,寧嘉才八九歲,黃毛小丫頭。   “騙人!”康康一下就戳穿了我的謊言。caoporen超碰在线视频   我不耐煩起來,喝道︰“行了,別吵!藍波,說你的打算。”caopor男频超碰   無論他如何對我,他永遠是我的主人。   “啊?”藍波傻了眼,“那怎麼辦……咱們得躲起來!”caoprn超碰碰免费视频   機器人第一法則︰機器人不得傷害人類,或袖手旁觀坐視人類受到傷害。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo